franciscosalti

מסלולים 0
עוקבים2
הבא3

זָכָר
קשרים חברתיים
הוא היה
Progressive hypogonadism seems to drive a process leading to deposition of adipose tissue and insulin resistance that, as part of a vicious cycle, further aggravates hypogonadism in KS (Gravholt et al., 2018). Patients should be educated about the positive effects and potential side effects of treatment and formulation options to participate in treatment decisions. Along with the many other specific aspects of care in KS, we find that there is a genuine need for a dedicated guideline, preferably based on an international collaboration. Klinefelter syndrome (KS; 47,XXY) is the most common sex chromosome abnormality in males (150 per 100,000 males).
In absence of a specific guideline for clinical management in KS, the way testosterone treatment is implemented is highly variable and dependent on clinician experience, patient preferences, and availability of formulation and possibly also insurer’s perception of the role of treatment, rather than on data-driven safety and efficacy. In regard to testosterone supplementation, a future guideline should also give specific aims for treatment in KS, preferably by evaluation of measurable predefined endpoints or intermediate endpoints, such as the level of luteinizing hormone (LH), testosterone, hemoglobin, bone mineral density, quality of life measures, libido, cognitive functioning, learning ability, and so on. There continues to be disagreement as to if testosterone treatment in the absence of hypergonadotropism, including boys with KS prior to and in early puberty, is clinically indicated.
In mammals with more than one X chromosome, the genes on all but one X chromosome are not expressed; this is known as X inactivation. This XXY chromosome arrangement is one of the most common genetic variations from the XY karyotype, occurring in approximately one in 500 live male births. Nondisjunction occurs when sister chromatids on the sex chromosome, in this case an X and an X, fail to separate. Another mechanism for retaining the extra chromosome is through a nondisjunction event during meiosis II in the egg. The relevant nondisjunction in meiosis I occurs when homologous chromosomes, in this case the X and Y or two X sex chromosomes, fail to separate, producing a sperm with an X and a Y chromosome or an egg with two X chromosomes.
In the following, we present a condensation of the available literature reporting health outcomes of testosterone treatment in KS in adults, and, when available in boys and adolescents. As such, major guidelines for testosterone treatment all agree that hypogonadism in men should be treated (Salter & Mulhall, 2019). "He will need testosterone replacement therapy when he is older since his body will produce low testosterone. Will he be denied his gender-affirming care?" "Gender-affirming care is just not for transgender youth," she explained, asserting that it would impact her son, who will require testosterone replacement therapy later in life due to low natural testosterone production. The global market for Klinefelter Syndrome therapeutics is significantly driven by advancements in hormonal therapy, which have broadened treatment options and bolstered confidence among healthcare professionals.
Treatment with exogenous testosterone suppresses the endogenous hypothalamic–pituitary–gonadal axis in post-pubertal males. Boys treated with oxandrolone experienced advanced bone age even with safety stopping and dose-reduction criteria in place (Davis et al., 2017). We conducted a cross-sectional study using high-resolution peripheral Quantitative Computed Tomography scanning of tibia and radius enabling a view of the microarchitecture of both trabecular and cortical bone. Several cross-sectional studies have documented decreased bone mineral density among men with KS in comparison with controls during a broad age range (Bojesen et al., 2011; Ferlin et al., 2011; van den Bergh et al., 2001). Hypogonadism is in itself linked to reduced bone mineral density, thus leading to an increased risk of fractures and osteoporosis.
To our knowledge there are no widely accepted specific guidelines for overall care of KS or even for testosterone supplementation in KS. In today’s clinical practice, treatment of patients with disease should preferably follow international guidelines representing the best practice advice based on condensation of the available research by leading experts. Patients referred to our clinic often describe how physicians aware of the diagnosis of KS have been unknowing about the need for testosterone supplementation (Chang, Christiansen, et al., 2019). However, from clinical experience, not all individuals with KS are offered such treatment (Chang, Biltoft, et al., 2019).
This review seeks to outline the current knowledge about how supplementation with testosterone is being carried out in boys and men with KS and to present available evidence related to the health effects of testosterone supplementation in KS. Collectively, beneficial effects of testosterone treatment on overall health in KS are described with few apparent adverse effects. For this descriptive review, we present an overview of literature describing health-related outcomes of testosterone treatment in KS and outline the clinical applications of testosterone treatment in KS. However, in November 2024, Nicklow also went viral after posting a TikTok about the threat to Theodore's future treatment if there is a potential ban on gender-affirming care, which can include testosterone shots. "He will need testosterone replacement therapy when he goes through puberty. That is gender-affirming care. I am scared that gender-affirming care will be banned on a federal level."
The global Klinefelter Syndrome therapeutics market faces significant challenges due to a lack of awareness about the condition among healthcare providers, which leads to delays in diagnosis and referrals to specialists. Global klinefelter syndrome therapeutics market is segmented by treatment type, route of administration (trt), clinical focus, end-user and region. Because of (primary) hypogonadism, individuals often have a low serum testosterone level, but high serum follicle-stimulating hormone and luteinizing hormone levels, hypergonadotropic hypogonadism. In particular, research exploring the psychological, social, and socioeconomic considerations in management of patients with KS could shed light on important underlying mechanisms for underdiagnosis and undertreatment in this population. Patients with KS may experience various degrees impairment in language and executive function (concept formation, problem-solving, and task switching).14 An impaired self-awareness and learning difficulties exhibited in some KS patients could potentially lead to limited recognition of the signs and symptoms of hypogonadism, although it remains to be seen if this reliably translates to a lack of capacity to recognize symptoms of hypogonadism.15 Without strong family or social support, patients with KS may be less able to seek evaluation or treatment for their condition.
http://110.41.167.73:18001/mosesonus80287/3861794/wiki/Do-Testosterone-Supplements-Work%3F-What-You-

דפדף במוזיקה

חנות

המוזיקה שלך

franciscosalti

אמנים לעקוב

רצועות מובילות שבועיות

Buddhist Councils and Important Texts

Indus Valley Civilization - Art & Culture

תוֹר